Physical Activity as Intervention Against Age-related Loss of Muscle Mass and Function

NCT02123641 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 451

Last updated 2017-09-25

No results posted yet for this study

Summary

A minimum of 450 healthy individuals (62-70 years old) will be recruited.

Each individual will be randomized into one of three groups stratified according to gender (M/F), BMI (≤28/\>28), and 30 sec chair stand (≤11/\>11). The three groups are Heavy resistance training (n=150), moderate intensity training (n=150), and control (n=150, no training).

Assessments will be performed at baseline, after 12 months of intervention. Furthermore, follow up will be performed after 2,4,7, and 10 years.

The primary outcome is change in leg extensor power after the intervention and during follow up.

The primary hypothesis is that by applying the intention-to-treat analysis, the moderate intensity training group will increase leg extensor power just as much as the heavy resistance training group. The two training groups will increase muscle power more than the control group.

Conditions

  • Muscle Weakness
  • Muscle Loss
  • Sarcopenia
  • Physical Activity

Interventions

OTHER

Heavy resistance training

Supervised heavy resistance training three times weekly for 52 weeks.

OTHER

Moderate intensity training

Moderate intensity training supervised once weekly and home based unsupervised two times weekly for 52 weeks.

OTHER

Control

No training

Sponsors & Collaborators

  • University of Copenhagen

    collaborator OTHER
  • Hvidovre University Hospital

    collaborator OTHER
  • Bispebjerg Hospital

    lead OTHER

Principal Investigators

  • Kasper Dideriksen, PhD stud · Bispebjerg Hospital

  • Anne Gylling, PhD stud · Bispebjerg Hospital

  • Christian Eriksen, PhD stud · Bispebjerg Hospital

  • Michael Kjaer, MD, Proff · Bispebjerg Hospital

  • Andreas Ziegler, PhD stud · Bispebjerg Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
62 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-04-30
Primary Completion
2028-06-30
Completion
2028-06-30

Countries

  • Denmark

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02123641 on ClinicalTrials.gov